Guests/Speakers
Terri Conneran, Dr. Jacob Kaufman
KRAS Biomarker Lung Cancer Treatments Explained
KRAS biomarker lung cancer: In this video you will learn the answers to these questions:
- What are the different types of KRAS biomarker lung cancer?
- What does my sub mutation mean for my treatment?
KRAS Biomarker and Lung Cancer
According to Dr. Jacob Kaufman, of The James Cancer Center at Ohio State University, treatment for patients with #KRAS Biomarker #lungcancer should be personalized to each individual patient’s specific cancer. Lung cancer specialists, like Dr. Kaufman, taylor the best possible treatment for each patient. These specialists are also called thoracic oncologists.
Not All KRAS Biomarker Lung Cancers Are the Same
In this KRAS Hope With Answers℠ video, Terri Conneran, a KRAS-positive lung cancer patient and advocate, talks with Dr. Kaufman about the “new for 2022” approved treatments for a specific sub mutation of KRAS biomarker lung cancer – G12C. The FDA has approved the very first treatment for KRAS Biomarker lung cancer that has the G12C sub mutation. This is hopeful news for all KRAS patients since researchers are actively working on finding personalized treatments for the other sub mutations of KRAS biomarker lung cancer. (Drugs that are effective for patients with the G12C sub mutation of their lung cancer will not be effective for the other KRAS sub mutations.)
KRAS Biomarker Hope With Answers℠ Videos
Available online, anytime you need it and anywhere you are, Hope With Answers℠ videos pair lung cancer patients with leading lung cancer doctors. The patients ask the questions that matter most to lung cancer patients. And, they get the answers from doctors who specialize in lung cancer. These lung cancer specialists dedicate their careers to staying up to date on the best tests, the latest effective treatment options, and what exciting things are on the horizon to help lung cancer patients. The Hope With Answers℠ video series includes videos on biomarker testing, staging in lung cancer, targeted therapies, immunotherapies, thoracic surgery, KRAS biomarker, ALK biomarker, clinical trials, and more. The videos are designed as stepping stones. Intro videos discuss the most basic information. Intermediate videos offer more profound knowledge. And, In-Depth videos provide the most intricate details.
